A surrogate cell‐based SARS‐CoV‐2 spike blocking assay

To monitor infection by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and successful vaccination against coronavirus disease 2019 (COVID‐19), the kinetics of neutralizing or blocking anti‐SARS‐CoV‐2 antibody titers need to be assessed. Here, we report the development of a quick an...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuh, Wolfgang, Baus, Lena, Steinmetz, Tobit, Schulz, Sebastian R., Weckwerth, Leonie, Roth, Edith, Hauke, Manuela, Krause, Sara, Morhart, Patrick, Rauh, Manfred, Hoffmann, Markus, Vesper, Niklas, Reth, Michael, Schneider, Holm, Jäck, Hans‐Martin, Mielenz, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
New Technology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646767/
https://www.ncbi.nlm.nih.gov/pubmed/34547822
http://dx.doi.org/10.1002/eji.202149302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646767/
https://www.ncbi.nlm.nih.gov/pubmed/34547822
http://dx.doi.org/10.1002/eji.202149302

Ejemplares similares